This study aimed to investigate the effects of a pine nut albumin hydrolysate (fraction< 3
kDa) and of its short peptide derivative, Trp-Tyr-Pro-Gly-Lys (WYPGK), on synaptic plasticity …

Stroke is one of the devastating clinical conditions that causes death and permanent
disability. Its occurrence causes the reduction of oxygen and glucose supply, resulting in …

Widespread death of transplanted mesenchymal stem cells (MSCs) hampers the
development of stem cell therapy for Alzheimer disease (AD). Cell pre-conditioning might …

Alzheimer's disease (AD) as a dementia and neurodegenerative disease, is mostly
prevalent among people more than 65 years. AD is mostly manifested in the form of …

Mesenchymal stem cells (MSCs) have provided a promising tool for cell therapy. Umbilical
cord (UC) is one of the best sources of MSCs since its collection is noninvasive, and …

Neurodegenerative diseases are neurological disorders that become more prevalent with
age, usually caused by damage or loss of neurons or their myelin sheaths, such as …

No cure yet exists for devastating Alzheimer's disease (AD), despite many years and
humongous efforts to find efficacious pharmacological treatments. So far, neither designing …

Dramatic advancement has been made in recent decades to understand the basis of
autoimmunity-mediated neurological diseases. These diseases create a strong influence on …

Neurological disorders, such as stroke, are triggered by a loss of neurons and glial cells.
Ischemic stroke remains a substantial problem for industrialized countries. Over the previous …

Neurological diseases, including dementias such as Alzheimer's disease (AD) and fronto-
temporal dementia (FTD) and degenerative motor neuron diseases such as amyotrophic …